drugset / Trial / NCT02912533
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
Open-label
Summary
The purpose of this study is to investigate the safety and efficacy for 52-week dosing of JR-131 in renal anemia patients with chronic kidney disease (CKD).
Timeline
- Start
- 2016-09
- Primary completion
- 2018-03
- Completion
- 2018-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JR-131 | Unknown | — | — |